Condition: Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Cancer · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
This description comes directly from the study's public registry record.
Tiffany Shiles · 813-745-2948 · Tiffany.Shiles@moffitt.org
Always discuss trial participation with your own doctor first.
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Oregon Health and Science University | Portland, Oregon, United States | Recruiting |
| University of Virginia Comprehensive Cancer Center | Charlottesville, Virginia, United States | Recruiting |
| Inova Schar Cancer Institute | Fairfax, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05080946